EchoSolv AS vs Aorta-CAD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

EchoSolv AS

by Echo IQ

Aorta-CAD

by Imagen Technologies

AI Verdict

EchoSolv AS is an AI-powered clinical decision support tool for cardiologists, focusing on identifying patients at risk for severe aortic stenosis by analyzing echocardiogram measurements. Conversely, Aorta-CAD assists radiologists and other physicians in detecting signs of aortic atherosclerosis and ectasia on chest X-rays. While both are FDA-cleared, cloud-based AI tools addressing aortic conditions, they utilize different imaging modalities and target distinct diagnostic challenges within cardiovascular care.

Choose EchoSolv AS if…

Choose EchoSolv AS if your cardiology practice requires an AI-powered clinical decision support tool to efficiently and accurately identify patients at high risk for severe aortic stenosis from echocardiogram measurements. This tool is ideal for providing a second reader perspective and prioritizing studies for closer review, integrating seamlessly into existing PACS workflows without requiring EMR integration.

View EchoSolv AS →

Choose Aorta-CAD if…

Choose Aorta-CAD if your radiology department or primary care clinic needs AI assistance to detect signs of Aortic Atherosclerosis and Aortic Ectasia on routine chest X-rays. This tool is best suited for improving the accuracy and immediacy of frontline diagnostic imaging by highlighting subtle findings, thereby reducing misses in a high-volume X-ray reading environment.

View Aorta-CAD →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	EchoSolv AS	Aorta-CAD
Deployment	Cloud-based	Cloud-based software that integrates into existing chest X-ray workflows and Picture Archiving and Communication System (PACS) viewers.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoSolv AS

Both tools emphasize seamless integration into existing workflows. However, Tool A (EchoSolv AS) highlights 'ultra-fast risk detection (under 3 seconds)' and 'no EMR integration required,' suggesting a potentially simpler and faster deployment and daily use experience. Its measurement-based AI may also simplify data input.

Clinical Value

Tie

Both tools are FDA-cleared and offer significant clinical value by improving the detection of serious cardiac conditions within their respective domains. Tool A (EchoSolv AS) demonstrates high accuracy for severe aortic stenosis, while Tool B (Aorta-CAD) shows a notable reduction in misses for aortic atherosclerosis and ectasia in clinical studies. Both provide strong, specific clinical validation results.

Pricing & Value

EchoSolv AS

While both tools require direct contact for specific pricing, Tool A (EchoSolv AS) provides more transparency by outlining a subscription-based model and a clear pathway for reimbursement with identified CPT codes and expected rates. This offers healthcare providers a better understanding of the potential financial value and adoption path.

Enterprise Readiness

EchoSolv AS

Both tools are cloud-based, FDA-cleared, HIPAA compliant, and have BAAs, indicating strong foundational readiness. However, Tool A (EchoSolv AS) further demonstrates enterprise readiness with explicit mention of SOC 2 Type II certification and successful deployment in a large academic medical center like Mount Sinai Health System.

Innovation

EchoSolv AS

While both leverage AI, Tool A (EchoSolv AS) presents a more distinct innovative approach with its 'measurement-based AI' that analyzes numerical data rather than images and explicitly states it 'does not use LVOT measurements.' This differentiates it from typical image-based deep learning solutions. [JSON]

Support & Docs

EchoSolv AS

Tool A (EchoSolv AS) provides more explicit details regarding its support and documentation, including a 'Trust Center' with SOC2 Type II and HIPAA audit reports, and an 'extensive suite of supporting documentation' for reimbursement. Tool B (Aorta-CAD) offers less specific information in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	EchoSolv AS	Aorta-CAD
Name	EchoSolv AS	Aorta-CAD
Company	Echo IQ	Imagen Technologies
Description	EchoSolv AS is an FDA-cleared, AI-powered clinical decision support platform by Echo IQ that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows.	Aorta-CAD by Imagen Technologies is an FDA-cleared, cloud-based AI software that assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays, integrating seamlessly into existing workflows.
Primary Function	Identifies patients at risk for severe aortic stenosis from echocardiograms.	Assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays.
Input Data Type	Echocardiogram measurements (numerical measurements, not images)	Chest X-rays
Key Benefit (as per description)	Identify high-probability severe aortic stenosis (sAS) patients accurately, quickly, simply.	Improving the accessibility, accuracy, and immediacy of frontline diagnostic imaging.

Videos

Demos, reviews, and walkthroughs featuring EchoSolv AS and Aorta-CAD.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific cardiac conditions do these AI tools assist in identifying?

EchoSolv AS is designed to identify patients at risk for severe aortic stenosis (sAS) with high accuracy and efficiency. Aorta-CAD assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays.

Which imaging modalities are utilized by each AI tool for analysis?

EchoSolv AS analyzes numerical measurements derived from echocardiograms, rather than directly analyzing images. Aorta-CAD, on the other hand, utilizes deep learning algorithms to analyze chest X-ray images.

How do these tools integrate into a physician's existing clinical workflow?

EchoSolv AS is designed to fit existing workflows, integrating with PACS and not requiring EMR integration. Aorta-CAD seamlessly integrates into existing X-ray reading workflows, creating annotations via an overlay that can be toggled on or off.

What are the primary outputs or forms of assistance each tool provides to the physician?

EchoSolv AS provides consistent severe AS probability and guideline checks from measurements, offering second reader support to help prioritize studies for closer review. Aorta-CAD detects and highlights radiographic findings suggestive of Aortic Atherosclerosis and Aortic Ectasia, presenting them as annotations on the X-ray image.

For which medical specialties are these AI tools primarily intended?

EchoSolv AS is primarily intended for Cardiology and Cardiothoracic Surgery. Aorta-CAD is designed to assist physicians across Cardiology, Internal Medicine, and Radiology, including radiologists and PCPs.

What clinical performance metrics or benefits have been demonstrated by each tool?

EchoSolv AS offers ultra-fast risk detection in under 3 seconds and identifies high-probability severe AS patients accurately and efficiently. Aorta-CAD has demonstrated a 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta in a clinical study.